Home » Topics » Regulatory » Patents

Patents
RSS

Toll-like receptor 4 antagonists discovered at TaiwanJ Pharmaceuticals

Sep. 18, 2018

Zhejiang Beta Pharma patents fibroblast growth factor receptor inhibitors

Sep. 17, 2018

Merck & Co. synthesizes new IDO1 inhibitors

Sep. 14, 2018

Hanyang University presents new MAPK 10 inhibitors

Sep. 14, 2018

Arrowhead Pharmaceuticals patents RNAi for thromboembolic disorders

Sep. 14, 2018

Eisai divulges new hSTING agonists for cancer

Sep. 13, 2018

Ono Pharmaceutical and Gilead Sciences identify new BTK inhibitors

Sep. 13, 2018

Galapagos and AbbVie Sarl present CFTR mutant correctors

Sep. 13, 2018

University of Florida patents vincamine analogues

Sep. 13, 2018

Janssen Pharmaceutica presents OGA inhibitors

Sep. 12, 2018

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...